The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001001381
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
26/07/2026
Date registered
Help: Date registered
14/08/2026
Date last updated
Help: Date last updated
14/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
14/08/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
DEXA-DENT: DEXAmethasone as an analgesic adjunct in the management of acute atraumatic DENTal pain: a pragmatic, triple-blind, parallel group, phase 3 randomised placebo-controlled trial
Scientific title
DEXA-DENT: Efficacy of DEXAmethasone as an analgesic adjunct in the management of acute atraumatic DENTal pain: a pragmatic, triple-blind, parallel group, phase 3 randomised placebo-controlled trial
Additional trial identifiers [1] 317851 0
NIL
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Dental pain 343018 0
Condition category
Condition code
Oral and Gastrointestinal 339108 339108 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Single dose of 8mg oral dexamethasone.
Administered as two 4mg capsules by treating nurse during their presentation at the Emergency Department (ED).
Adherence will be monitored as per usual medication administration - oral medication provided along with cup of water, observed to swallow medication with sip of water.

Capsules made by de-blistering and over encapsulation of 4mg dexamethasone tablets into hard gelatin capsules filled with partially pregelatinized maize starch.
Intervention code [1] 334889 0
Treatment: Drugs
Description of the comparator or control
Single dose placebo
- 2x hard gelatin capsules filled with partially pregelatinized maize starch. Identical size and colour to dexamethasone capsules.
Control group
Placebo

Outcomes
Primary outcome [1] 346349 0
Participant pain
Timepoint [1] 346349 0
12 hours after medication administration
Secondary outcome [1] 465496 0
Participant pain
Timepoint [1] 465496 0
24, 48 and 72 hours after medication administration
Secondary outcome [2] 465497 0
Cumulative opioid use
Timepoint [2] 465497 0
72 hours after medication administration
Secondary outcome [3] 465498 0
Participant satisfaction
Timepoint [3] 465498 0
72 hours after medication administration
Secondary outcome [4] 465499 0
Adverse effects including allergic reactions, insomnia, gastrointestinal upset, mood changes
Timepoint [4] 465499 0
72 hours after medication administration
Secondary outcome [5] 465500 0
Dental intervention
Timepoint [5] 465500 0
72 hours after medication administration
Secondary outcome [6] 465501 0
Frequency of unplanned ED representation
Timepoint [6] 465501 0
72 hours after medication administration

Eligibility
Key inclusion criteria
All adult (greater than or equal to 18 years old) patients presenting to the ED with acute atraumatic dental pain. This is defined as pain originating from the tooth or surrounding structures (including gingiva) in the absence of trauma, including but not exclusive to periodical abscess, periodontal abscess, gingivitis and pulpitis.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Unable or unwilling to consent to study
No telephone number nor ability to engage in follow up contact
Clinical history of trauma related to current presentation
Clinical indication for acute surgical management such as deep space infection
Clinical indication for inpatient management including intravenous medications
Systemically unwell including severe infection, sepsis
Contraindication to corticosteroids including severe immunosuppression (transplant patients, patients undergoing active chemotherapy), clinical concern for steroid-induced psychiatric reactions
Known or suspected hypersensitivity to any excipient contained in either dexamethasone or placebo
Altered mental state including drug or alcohol intoxixcation
Inability to take oral medication

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Pre-randomised concealed bottles containing active or placebo capsules of identical appearance.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
1:1 block randomisation using a computer generated sequence with block size 6-8.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Efficacy
Statistical methods / analysis
A change of two points on the numeric pain rating scale (NPRS) is considered to be clinically significant.
Based on a standard deviation of 3.7 from a previous prospective study, this project requires 54 participants in each arm to detect a difference at a power of 80% and a two-sided alpha of 0.05. A judicious 50% loss to follow up has been anticipated, leading to a final enrolment target of 216 participants.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 29915 0
Gold Coast University Hospital - Southport
Recruitment postcode(s) [1] 46272 0
4215 - Southport

Funding & Sponsors
Funding source category [1] 322391 0
Charities/Societies/Foundations
Name [1] 322391 0
Emergency Medicine Foundation
Country [1] 322391 0
Australia
Funding source category [2] 322567 0
Charities/Societies/Foundations
Name [2] 322567 0
Australasian College for Emergency Medicine
Country [2] 322567 0
Australia
Primary sponsor type
Hospital
Name
Gold Coast University Hospital
Address
Country
Australia
Secondary sponsor category [1] 325487 0
None
Name [1] 325487 0
Address [1] 325487 0
Country [1] 325487 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320892 0
Gold Coast Hospital and Health Service Human Research Ethics Committee
Ethics committee address [1] 320892 0
Ethics committee country [1] 320892 0
Australia
Date submitted for ethics approval [1] 320892 0
12/11/2025
Approval date [1] 320892 0
19/05/2026
Ethics approval number [1] 320892 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151982 0
Dr Colin Mak
Address 151982 0
Gold Coast University Hospital, 1 Hospital Boulevard, Southport, Queensland 4215
Country 151982 0
Australia
Phone 151982 0
+61 491129791
Fax 151982 0
Email 151982 0
Contact person for public queries
Name 151983 0
Colin Mak
Address 151983 0
Gold Coast University Hospital, 1 Hospital Boulevard, Southport, Queensland 4215
Country 151983 0
Australia
Phone 151983 0
+61 491129791
Fax 151983 0
Email 151983 0
Contact person for scientific queries
Name 151984 0
Colin Mak
Address 151984 0
Gold Coast University Hospital, 1 Hospital Boulevard, Southport, Queensland 4215
Country 151984 0
Australia
Phone 151984 0
+61 491129791
Fax 151984 0
Email 151984 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.